


Healthcare News Roundup: Generic Pharmaceuticals
HSMN NewsFeed - 29 May 2009
Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
HSMN NewsFeed - 19 May 2009
Impax Receives FDA Approval for Generic Precose Tablets, 25 mg, 50 mg and 100 mg
Impax Receives FDA Approval for Generic Precose Tablets, 25 mg, 50 mg and 100 mg
HSMN NewsFeed - 8 May 2009
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
HSMN NewsFeed - 22 Apr 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
HSMN NewsFeed - 14 Apr 2009
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
